268 related articles for article (PubMed ID: 27988503)
1. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
Pierce VM; Eversley JS; Tran TK; Rosenberg ES
Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
[TBL] [Abstract][Full Text] [Related]
2. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
Pyne MT; Mallory M; Hillyard DR
J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and monitoring of HCV infection using the cobas
Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
[TBL] [Abstract][Full Text] [Related]
4. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
[TBL] [Abstract][Full Text] [Related]
5. The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.
Chevaliez S; Bouvier-Alias M; Rodriguez C; Soulier A; Poveda JD; Pawlotsky JM
J Clin Microbiol; 2013 Apr; 51(4):1078-82. PubMed ID: 23325825
[TBL] [Abstract][Full Text] [Related]
6. Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.
Vermehren J; Maasoumy B; Maan R; Cloherty G; Berkowski C; Feld JJ; Cornberg M; Pawlotsky JM; Zeuzem S; Manns MP; Sarrazin C; Wedemeyer H
Clin Infect Dis; 2016 May; 62(10):1228-1234. PubMed ID: 26908802
[TBL] [Abstract][Full Text] [Related]
7. Verification of the Roche cobas
Tan NK; Carrington D; Pope CF
J Med Microbiol; 2018 Dec; 67(12):1711-1717. PubMed ID: 30325300
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.
Tung YC; Ke LY; Lu PL; Lin KH; Lee SC; Lin YY; Chou LC; Tsai WC
Kaohsiung J Med Sci; 2015 Apr; 31(4):188-93. PubMed ID: 25835274
[TBL] [Abstract][Full Text] [Related]
11. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.
Vermehren J; Colucci G; Gohl P; Hamdi N; Abdelaziz AI; Karey U; Thamke D; Zitzer H; Zeuzem S; Sarrazin C
J Clin Microbiol; 2011 Sep; 49(9):3309-15. PubMed ID: 21752967
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
[TBL] [Abstract][Full Text] [Related]
13. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
Vermehren J; Kau A; Gärtner BC; Göbel R; Zeuzem S; Sarrazin C
J Clin Microbiol; 2008 Dec; 46(12):3880-91. PubMed ID: 18799708
[TBL] [Abstract][Full Text] [Related]
14. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the QIAGEN artus HCV QS-RGQ test with the Roche COBAS Ampliprep/COBAS TaqMan HCV test v2.0 for the quantification of HCV-RNA in plasma samples.
Schønning K
J Clin Virol; 2014 Aug; 60(4):323-7. PubMed ID: 24894603
[TBL] [Abstract][Full Text] [Related]
16. HCV RNA detection in HCV antibody-positive patients with the COBAS AmpliPrep/COBAS TaqMan HCV test, v2.0 in comparison with FDA-approved nucleic acid tests.
Butcher A; Aslam S; Hemyari P; Cowen U; Heilek G
J Clin Virol; 2014 Aug; 60(4):336-40. PubMed ID: 24881014
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.
Sarrazin C; Dragan A; Gärtner BC; Forman MS; Traver S; Zeuzem S; Valsamakis A
J Clin Virol; 2008 Oct; 43(2):162-8. PubMed ID: 18692434
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
[TBL] [Abstract][Full Text] [Related]
19. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Wirden M; Larrouy L; Mahjoub N; Todesco E; Damond F; Delagreverie H; Akhavan S; Charpentier C; Chaix ML; Descamps D; Calvez V; Marcelin AG
J Clin Virol; 2017 Nov; 96():49-53. PubMed ID: 28950186
[TBL] [Abstract][Full Text] [Related]
20. Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study.
Colucci G; Ferguson J; Harkleroad C; Lee S; Romo D; Soviero S; Thompson J; Velez M; Wang A; Miyahara Y; Young S; Sarrazin C
J Clin Microbiol; 2007 Nov; 45(11):3595-600. PubMed ID: 17898157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
